Perrigo Company (
) will begin trading ex-dividend on February 27, 2013. A cash
dividend payment of $0.09 per share is scheduled to be paid on
March 19, 2013. Shareholders who purchased PRGO stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
represents an 12.5% increase over the same period a year ago.
The previous trading day's last sale of PRGO was $113.31,
representing a -6.18% decrease from the 52 week high of $120.78 and
a 20.8% increase over the 52 week low of $93.80.
PRGO is a part of the Consumer Durables sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). PRGO's current earnings per share, an indicator of a company's
profitability, is $4.61. Zacks Investment Research reports PRGO's
forecasted earnings growth in 2013 as 12.84%, compared to an
industry average of 8.9%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to PRGO through an Exchange
Traded Fund [ETF]?
The following ETF(s) have PRGO as a top-10 holding:
- SPDR S&P Pharmaceuticals ETF (
- iShares NASDAQ Biotechnology Index Fund (
- iShares Dow Jones U.S. Pharmaceutical Index Fund (
- First Trust NASDAQ-100 Ex-Technology Sector Index Fund (
The top-performing ETF of this group is QQXT with an increase of
8.94% over the last 100 days. XPH has the highest percent weighting
of PRGO at 4.35%.